Pure Global
NCT06292624

Effectiveness of Intermittent Vacuum Therapy Combined With Aerobic Exercise in Individuals With Diabetes Mellitus

Effectiveness of Intermittent Vacuum Therapy Combined With Aerobic Exercise in Improving Lower Limb Oxygenation and Circulation in Individuals With Diabetes Mellitus
The Hong Kong Polytechnic University·ClinicalTrials.gov·device·Device trialRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Intermittent vacuum therapy (Weyergans High Care® Medial, Germany)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The Hong Kong Polytechnic University
Location
Hong Kong, China
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Apr 30, 2024
Enrollment
12 participants
Primary outcome

Muscle oxygenation,Muscle oxygenation

Summary

Consequences of the compromised vascular system in diabetes mellitus (DM) are among the most
 devastating complications. Reduction in blood flow and oxygen uptake of skeletal muscle leads
 to muscle fatigue and impaired skeletal muscle post-exercise adaptation. Recent studies
 showed that intermittent vacuum therapy (IVT) augments the blood flow of the foot in people
 with DM. This pilot study investigates the effects of combined IVT and aerobic exercise in
 improving lower limb muscle oxygenation and distal circulation in individuals with DM.
 Positive results of the study shed light on strategy that enhances the effectiveness of
 aerobic exercise in people with DM.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06292624
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06292624 through Pure Global AI's free database. This phase not specified trial is sponsored by The Hong Kong Polytechnic University and is currently Recruitment Completed. The study focuses on Diabetes Mellitus. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.